All In Biotech

Free tool

FAERS Monitor: Imvexxy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026Source: FDA FAERS (openFDA)Methods & limitations

Reports naming NDA 208564 or its brand name (Imvexxy, Estradiol). Reports on generic versions are filed under their own applications.

Reports

0

Serious

0

Hospitalization

0

Death reported

0

Any cause; not necessarily from the drug

No FAERS reports match. Try the generic name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.